Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow-to-Debt Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC cash flow-to-debt ratio. Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of ₫-135.66 Billion could theoretically repay 0% of its total liabilities (₫870.62 Billion) in one year. Check DBD capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Cash flow-to-debt ratio of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. Historical debt coverage capacity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. Check how high is Binh Dinh Pharmaceutical and Medical Equ's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow-to-Debt Ratio by Year (2020–2025)
Binh Dinh Pharmaceutical and Medical Equipment JSC cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. For the full cash flow conversion analysis, see Binh Dinh Pharmaceutical and Medical Equ cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (VND) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | ₫615.19 Billion | ₫862.89 Billion | ▲ +62.4% |
| 2024 | 0.44x | ₫264.73 Billion | ₫603.07 Billion | ▼ -17.0% |
| 2023 | 0.53x | ₫293.99 Billion | ₫556.07 Billion | ▲ +73.2% |
| 2022 | 0.31x | ₫165.01 Billion | ₫540.58 Billion | ▲ +8.8% |
| 2021 | 0.28x | ₫117.57 Billion | ₫418.97 Billion | ▼ -40.9% |
| 2020 | 0.47x | ₫212.91 Billion | ₫448.78 Billion | — |